Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Josh Adler, Sourcewater Founder & CEO
Alan Kriz - Open Innovation and Investment
Christina Qi, Partner, Domeyard LP
Panelists include Sangbae Kim, Grant Allen, Alexander Zak, Sampriti Bhattachryya, Tom Ryden, and Maja Haji
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Natalya Baily, CEO & Cofounder, Accion
Jan Schnorr, CEO, C2Sense